| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 17238 | 2013 |
| First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ... New England Journal of Medicine 371 (23), 2167-2177, 2014 | 3745 | 2014 |
| Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a … H Wilke, K Muro, E Van Cutsem, SC Oh, G Bodoky, Y Shimada, ... The lancet oncology 15 (11), 1224-1235, 2014 | 2657 | 2014 |
| Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer S Peters, DR Camidge, AT Shaw, S Gadgeel, JS Ahn, DW Kim, SHI Ou, ... New England Journal of Medicine 377 (9), 829-838, 2017 | 2530 | 2017 |
| Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma J Weber, M Mandala, M Del Vecchio, HJ Gogas, AM Arance, CL Cowey, ... New England Journal of Medicine 377 (19), 1824-1835, 2017 | 2411 | 2017 |
| Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ... The Lancet 379 (9829), 1879-1886, 2012 | 2317 | 2012 |
| Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin’s lymphoma JM Connors, W Jurczak, DJ Straus, SM Ansell, WS Kim, A Gallamini, ... New England Journal of Medicine 378 (4), 331-344, 2018 | 811 | 2018 |
| Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ... The Lancet Oncology 19 (4), 521-536, 2018 | 583 | 2018 |
| Effect of supplementation of Bacillus subtilis LS 1-2 to broiler diets on growth performance, nutrient retention, caecal microbiology and small intestinal morphology S Sen, SL Ingale, YW Kim, JS Kim, KH Kim, JD Lohakare, EK Kim, HS Kim, ... Research in Veterinary Science 93 (1), 264-268, 2012 | 348 | 2012 |
| Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the … B Keam, SA Im, HJ Kim, DY Oh, JH Kim, SH Lee, EK Chie, W Han, ... BMC cancer 7, 1-11, 2007 | 254 | 2007 |
| Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer SM Gadgeel, AT Shaw, R Govindan, L Gandhi, MA Socinski, DR Camidge, ... Journal of Clinical Oncology 34 (34), 4079-4085, 2016 | 208 | 2016 |
| Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group TM Kim, SY Lee, YK Jeon, BY Ryoo, GJ Cho, YS Hong, HJ Kim, SY Kim, ... Annals of Oncology 19 (8), 1477-1484, 2008 | 187 | 2008 |
| Search for the direct production of charginos and neutralinos in final states with tau leptons in pp collisions with the ATLAS detector M Aaboud, G Aad, B Abbott, O Abdinov, B Abeloos, SH Abidi, ... The European Physical Journal C 78, 1-33, 2018 | 178* | 2018 |
| Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ... Annals of Oncology 27 (3), 417-423, 2016 | 164 | 2016 |
| Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis HS Kim, HJ Kim, SY Kim, TY Kim, KW Lee, SK Baek, MH Ryu, BH Nam, ... Annals of Oncology 24 (11), 2850-2854, 2013 | 162 | 2013 |
| Harpoon: a flow-level traffic generator for router and network tests J Sommers, H Kim, P Barford ACM SIGMETRICS Performance Evaluation Review 32 (1), 392-392, 2004 | 162 | 2004 |
| Exposure to volatile organic compounds and loss of pulmonary function in the elderly HI Yoon, YC Hong, SH Cho, H Kim, YH Kim, JR Sohn, M Kwon, SH Park, ... European respiratory journal 36 (6), 1270-1276, 2010 | 147 | 2010 |
| Characterization of large structural genetic mosaicism in human autosomes MJ Machiela, W Zhou, JN Sampson, MC Dean, KB Jacobs, A Black, ... The American Journal of Human Genetics 96 (3), 487-497, 2015 | 134 | 2015 |
| Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in β-amyloid-treated C6 glioma cells Y Kim, SY Lim, SH Rhee, KY Park, CH Kim, BT Choi, SJ Lee, YM Park, ... International journal of molecular medicine 17 (6), 1069-1075, 2006 | 130 | 2006 |
| HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L) 1 blockade in advanced non-small-cell lung cancer patients JH Shim, HS Kim, H Cha, S Kim, TM Kim, V Anagnostou, YL Choi, ... Annals of Oncology 31 (7), 902-911, 2020 | 123 | 2020 |
